List of Schedule III controlled substances (U.S.)
From Wikipedia, the free encyclopedia
This is the list of Schedule III controlled substances in the United States as defined in section 202 of the Controlled Substances Act (21 U.S.C. § 812) and 21 CFR 1308.13. The following findings are required for substances to be placed in this schedule:
- The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II.
- The drug or other substance has a currently[note 1] accepted medical use in treatment in the United States.
- Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The complete list of Schedule III substances is as follows. The Administrative Controlled Substances Code Number and Federal Register citation for each substance is included.
Stimulants
| ACSCN | Drug |
|---|---|
| 1405 | See 21 CFR 1308.13(b)(1) |
| 1228 | Benzphetamine[1] |
| 1645 | Chlorphentermine[1] |
| 1647 | Clortermine[1] |
| 1615 | Phendimetrazine[1] |
Depressants
| ACSCN | Drug |
|---|---|
| 2100 | Any derivative of barbituric acid[2][note 2] |
| 2510 | Chlorhexadol[2][note 2] |
| 2020 | Embutramide[3] |
| 2012 | FDA-approved oxybate products[4] |
| 2261 | Perampanel[5] |
| 7285 | Ketamine[6] |
| 7300 | Lysergic acid[2][note 2] |
| 7310 | Lysergic acid amide[2][note 2] |
| 2575 | Methyprylon[2][note 2] |
| 2600 | Sulfondiethylmethane[2][note 2] |
| 2605 | Sulfonethylmethane[2][note 2] |
| 2610 | Sulfonmethane[2][note 2] |
| 7295 | Tiletamine and zolazepam[7] |
Others
| ACSCN | Drug |
|---|---|
| 9400 | Nalorphine[2][note 2] |
Narcotics
| ACSCN | Drug |
|---|---|
| 9803 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium[2][note 2] |
| 9804 | Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[2][note 2] |
| 9807 | Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active nonnarcotic ingredients in recognized therapeutic amounts[2][note 2] |
| 9808 | Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[2][note 2] |
| 9809 | Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[2][note 2] |
| 9810 | Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, nonnarcotic ingredients in recognized therapeutic amounts[2][note 2] |
| 9064 | Buprenorphine[8] |
Steroids
| ACSCN | Drug |
|---|---|
| 4000 | Anabolic steroids |
Cannabinoid
| ACSCN | Drug |
|---|---|
| 7360 | FDA-approved products containing marijuana and products regulated by a state medical marijuana license[9][10] |
| 7369 | Dronabinol in sesame oil and encapsulated in a soft gelatin capsule[11] |
See also
Notes
- The use of the term "currently" in Wikipedia is deprecated per MOS:RELTIME, however its presence here is a direct quotation of the referenced Act.
- This substance was expressly scheduled by the Controlled Substances Act on October 27, 1970. The 1974 Federal Register ruling (by Administrator John R. Bartels, Jr.) merely organized its listing in the Code of Federal Regulations.